http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

Bromocriptine mesylate tablets are indicated in the treatment of the signs and symptoms of idiopathic or postencephalitic Parkinson's disease. As adjunctive treatment to levodopa (alone or with a peripheral decarboxylase inhibitor), bromocriptine mesylate therapy may provide additional therapeutic benefits in those patients who are currently maintained on optimal dosages of levodopa, those who are beginning to deteriorate (develop tolerance) to levodopa therapy, and those who are experiencing "end of dose failure" on levodopa therapy.

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

https://identifiers.org/MONDO:0001945 MONDO:0001945

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/CHEBI:3182 CHEBI:3182

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://dailymed.nlm.nih.gov/d...6b-b261-4262-9e06-f3180b419f8f drugInfo.cfm?setid=93a0696b-b261-4262-9e06-f3180b419f8f

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

NeuroDKG

Leoni Bücken

2021-03-28T18:10:59.894Z

http://purl.org/np/RAdzZfNP3F... RAdzZfNP3F

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/SymptomaticReliefIndication SymptomaticReliefIndication

Leoni Bücken

2021-03-28T18:10:59.894Z